Genetic and functional association of the immune signaling molecule 4-1BB (CD137/TNFRSF9) with type 1 diabetes

Journal of Autoimmunity

Volumn 25, Issue 1, 2005, Pages 13-20

  Cannons, Jennifer L ^a,d   Chamberlain, Giselle ^b   Howson, Joanna ^b   Smink, Luc J ^b   Todd, John A ^b   Peterson, Laurence B ^c   Wicker, Linda S ^b   Watts, Tania H ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c MERCK RESEARCH LABORATORIES   (United States)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

Congenic; Costimulation; Gene mapping; Nonobese diabetic mouse; T lymphocyte

Indexed keywords

ANTIBODY; CD137 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; INTERLEUKIN 2; PROTEIN SUBUNIT; TUMOR NECROSIS FACTOR RECEPTOR;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CELL FUNCTION; CELL GROWTH; CELL SURVIVAL; CONGENIC STRAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; IMMUNOCOMPETENT CELL; IMMUNOPATHOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD137; CELL LINE; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MICE; MICE, CONGENIC; MICE, INBRED C57BL; MICE, INBRED NOD; PHYSICAL CHROMOSOME MAPPING; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION;

EID: 22444434764     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaut.2005.04.007     Document Type: Article

References (31)

1. P.A. Lyons, W.W. Hancock, and P. Denny The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137 Immunity 13 2000 107 115
2. D.V. Serreze, and E.H. Leiter Genes and cellular requirements for autoimmune diabetes susceptibility in nonobese diabetic mice Curr Dir Autoimmun 4 2001 31 67
3. M. Croft Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat Rev Immunol 3 2003 609 620
4. T.H. Watts TNF/TNFR family members in costimulation of T cell responses Annu Rev Immunol 23 2005 23 68
5. J.L. Cannons, P. Lau, and B. Ghumman 4-1BBL induces cell division, sustains survival and enhances effector function of CD4 and CD8 T cells with similar efficacy J Immunol 167 2001 1313 1324
6. M.A. DeBenedette, T. Wen, and M.F. Bachmann Analysis of 4-1BB ligand-deficient mice and of mice lacking both 4-1BB ligand and CD28 reveals a role for 4-1BB ligand in skin allograft rejection and in the cytotoxic T cell response to influenza virus J Immunol 163 1999 4833 4841
7. J.T. Tan, J.K. Whitmire, R. Ahmed, T.C. Pearson, and C.P. Larsen 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses J Immunol 163 1999 4859 4868
8. B.S. Kwon, J.C. Hurtado, and Z.H. Lee Immune responses in 4-1BB (CD137)-deficient mice J Immunol 168 2002 5483 5490
9. + T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses J Exp Med 186 1997 47 55
10. I. Melero, W.W. Shuford, and S.A. Newby Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors Nat Med 3 1997 682 685
11. E.S. Halstead, Y.M. Mueller, J.D. Altman, and P.D. Katsikis In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses Nat Immunol 3 2002 536 541
12. E.M. Bertram, W. Dawicki, B. Sedgmen, J.L. Bramson, D.H. Lynch, and T.H. Watts A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8 T cell response to influenza in vivo J Immunol 172 2004 981 988
13. L. Diehl, G.J. van Mierlo, and A.T. den Boer In vivo triggering through 4-1BB enables Th-independent priming of CTL in the presence of an intact CD28 costimulatory pathway J Immunol 168 2002 3755 3762
14. V.Y. Taraban, T.F. Rowley, and L. O'Brien Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses Eur J Immunol 32 2002 3617 3627
15. K.F. May Jr., L. Chen, P. Zheng, and Y. Liu Anti-4-1BB monoclonal antibody enhances rejection of large tumor burden by promoting survival but not clonal expansion of tumor-specific CD8+ T cells Cancer Res 62 2002 3459 3465
16. B.R. Blazar, B.S. Kwon, A. Panoskaltsis-Mortari, K.B. Kwak, J.J. Peschon, and P.A. Taylor Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients J Immunol 166 2001 3174 3183
17. R.S. Mittler, T.S. Bailey, K. Klussman, M.D. Trailsmith, and M.K. Hoffmann Anti-4-1BB monoclonal antibodies abrogate T cell-dependent humoral immune responses in vivo through the induction of helper T cell anergy J Exp Med 190 1999 1535 1540
18. Y. Sun, H.M. Chen, and S.K. Subudhi Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease Nat Med 8 2002 1405 1413
19. Y. Sun, X. Lin, and H.M. Chen Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis J Immunol 168 2002 1457 1465
20. J. Foell, S. Strahotin, and S.P. O'Neil CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB × NZW F1 mice J Clin Invest 111 2003 1505 1518
21. Z.Q. Wu, A.Q. Khan, and Y. Shen 4-1BB (CD137) differentially regulates murine in vivo protein- and polysaccharide-specific immunoglobulin isotype responses to Streptococcus pneumoniae Infect Immun 71 2003 196 204
22. K. Saoulli, S.Y. Lee, and J.L. Cannons CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand J Exp Med 187 1998 1849 1862
23. R.H. Arch, and C.B. Thompson 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor κB Mol Cell Biol 18 1998 558 565
24. J.L. Cannons, K.P. Hoeflich, J.R. Woodgett, and T.H. Watts Role of the stress kinase pathway in signaling via the T cell costimulatory receptor 4-1BB J Immunol 163 1999 2990 2998
25. J.L. Cannons, Y. Choi, and T.H. Watts Role of TNF receptor-associated factor 2 and p38 mitogen-activated protein kinase activation during 4-1BB-dependent immune response J Immunol 165 2000 6193 6204
26. H.W. Lee, S.J. Park, B.K. Choi, H.H. Kim, K.O. Nam, and B.S. Kwon 4-1BB promotes the survival of CD8(+) T lymphocytes by increasing expression of Bcl-x(L) and Bfl-1 J Immunol 169 2002 4882 4888
27. F.A. Brook, E.P. Evans, and C.J. Lord The derivation of highly germline-competent embryonic stem cells containing NOD-derived genome Diabetes 52 2003 205 208
28. L. Myers, C. Takahashi, R.S. Mittler, R.J. Rossi, and A.T. Vella Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering Proc Natl Acad Sci U S A 100 2003 5348 5353
29. S.K. Seo, J.H. Choi, and Y.H. Kim 4-1BB-mediated immunotherapy of rheumatoid arthritis Nat Med 10 2004 1088 1094
30. G. Zheng, B. Wang, and A. Chen The 4-1BB costimulation augments the proliferation of CD4+CD25+ regulatory T cells J Immunol 173 2004 2428 2434
31. B.K. Choi, J.S. Bae, and E.M. Choi 4-1BB-dependent inhibition of immunosuppression by activated CD4+CD25+ T cells J Leukoc Biol 75 2004 785 791